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ABSTRACT
The completion of DNA synthesis in yeast is monitored by a checkpoint that requires MEC1 and RAD53.
Here we show that deletion of the Saccharomyces cerevisiae G1 cyclins CLN1 and CLN2 suppressed the
essential requirement for MEC1 function. Wild-type levels of CLN1 and CLN2, or overexpression of CLN1,
CLN2, or CLB5, but not CLN3, killed mec1 strains. We identified RNR1, which encodes a subunit of
ribonucleotide reductase, as a high-copy suppressor of the lethality of mec1 GAL1-CLN1. Northern analysis
demonstrated that RNR1 expression is reduced by CLN1 or CLN2 overexpression. Because limiting RNR1
expression would be expected to decrease dNTP pools, CLN1 and CLN2 may cause lethality in mec1 strains
by causing initiation of DNA replication with inadequate dNTPs. In contrast to mec1 mutants, MEC1 strains
with low dNTPs would be able to delay S phase and thereby remain viable. We propose that the essential
function for MEC1 may be the same as its checkpoint function during hydroxyurea treatment, namely,
to slow S phase when nucleotides are limiting. In a cln1 cln2 background, a prolonged period of expression
of genes turned on at the G1-S border, such as RNR1, has been observed. Thus deletion of CLN1 and
CLN2 could function similarly to overexpression of RNR1 in suppressing mec1 lethality.

C

YCLINS and cyclin-dependent kinases (CDKs)
have been shown to play important roles in many
eukaryotic cell cycle transitions. In the yeast Saccharomyces cerevisiae, the cyclins that normally control the G1
to S phase transition (START) are CLN1, CLN2, and
CLN3. The B-type cyclin, CLB5, can functionally substitute for the CLNs if it is overexpressed (Epstein and
Cross 1992; Schwob and Nasmyth 1993), or if the
B-type cyclin inhibitor, SIC1, is deleted (Schneider et al.
1996; Tyers 1996). The Cln proteins, when complexed
with the CDK encoded by CDC28, activate a number of
pathways, including activation of B-type cyclins (CLBs),
DNA replication, bud emergence, and microtubule organizing center duplication (see Lew et al. 1997 for a
recent review). Although CLNs are redundant for viability in an otherwise wild-type strain, there are significant
and qualitative differences between the CLNs as evidenced by their in vitro kinase activities, requirements
for other gene products, and ability to activate transcription of other genes (Benton et al. 1993; Cvrckovà and
Nasmyth 1993; Tyers et al. 1993; Vallen and Cross
1995; Levine et al. 1996). One specific difference between CLN1 and CLN2 compared to CLN3 is CLN3’s
ability to act as a strong transcriptional activator of cell
cycle-regulated genes containing promoter elements
regulated by the transcription factors SBF and MBF
(Tyers et al. 1993; Dirick et al. 1995; Stuart and Wit-
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tenberg 1995). It is likely that the predominant role
of Cln3 in the cell is the activation of transcription of
these gene classes. CLN3 appears to be less potent an
activator of most of the other pathways that are initiated
at START (Levine et al. 1996). Thus, in a wild-type
CLN strain, the three different cyclins complexed with
Cdc28p may act together leading to the coordinate activation of transcription and other START-associated processes.
A number of genes required directly for DNA replication have transcript levels that peak at or near the G1
to S phase transition. These genes are regulated by MBF,
having MCB (MluI cell cycle box) elements upstream
of their coding region (McIntosh 1993). One such
gene is RNR1, which shows about a 15-fold fluctuation
in RNA levels across the cell cycle (Elledge and Davis
1990). RNR1 and a related gene, RNR3, encode the
large a subunit of ribonucleotide reductase (Elledge
and Davis 1990). Ribonucleotide reductase is a tetrameric enzyme of the structure a2b2, which catalyzes the
formation of deoxyribonucleotides from ribonucleotides. The small b subunits are encoded by RNR2 and
RNR4 (Elledge and Davis 1987; Hurd et al. 1987;
Huang and Elledge 1997; Wang et al. 1997). Enzymatic
activity of the complex has been demonstrated to be
cell cycle regulated, peaking in early S phase (Lowden
and Vitols 1973). Because RNA levels of the small
subunits vary only approximately twofold or less during
the cell cycle and RNR3 is not essential for viability, it
is likely that Rnr1 levels are rate limiting for enzymatic
activity (Elledge and Davis 1990; Huang and Elledge
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1997). Strong evidence supporting this conclusion
comes from recent analysis of ribonucleotide reductase
activity in yeast extracts, which demonstrates that the
addition of Rnr1p increases enzymatic activity in vitro
(Wang et al. 1997). Furthermore, deletion of SML1,
which encodes a protein that binds Rnr1, increases the
dNTP levels in cells (Zhao et al. 1998). Inhibition of
ribonucleotide reductase activity by hydroxyurea (HU)
leads to depletion of dNTP pools (Yarbro 1992) and
results in cell cycle arrest in S phase in wild-type eukaryotic cells.
HU causes cell cycle arrest because there is a signaling
pathway, or S phase checkpoint (Weinert and Hartwell 1989; Weinert et al. 1994), that monitors the
completion of DNA replication and prevents mitosis
until replication is completed. In S. cerevisiae, the incomplete replication and stalled replication forks caused
by depletion of deoxyribonucleotide pools are likely
sensed by DNA polymerase ε, Dpb11p, or Rfc5p (Araki
et al. 1995; Navas et al. 1995; Sugimoto et al. 1996,
1997). The signal transduction pathway activated by HU
and required for cell cycle arrest and the transcriptional
induction of genes required for DNA synthesis and damage repair requires the kinases Mec1p, Rad53p, and
Dun1p (Allen et al. 1994; Kiser and Weinert 1996;
Pati et al. 1997). Activation of replication checkpoints
by HU or DNA polymerase a mutants induces phosphorylation of Rad53p that is MEC1 dependent (Sanchez
et al. 1996; Sun et al. 1996). This, coupled with the
observations that MEC1 is required for the damageinduced transcription of some genes that do not require
RAD53 for transcriptional induction (Kiser and Weinert 1996), and that deletion of MEC1 is suppressed by
overexpression of RAD53 (Sanchez et al. 1996), suggests
that Mec1p functions upstream of Rad53p.
Although checkpoint genes were originally hypothesized to be required only in cells subjected to perturbation, both MEC1 and RAD53 genes are required for
wild-type cell division in S. cerevisiae (Zheng et al. 1993;
Paulovich et al. 1997; Zhao et al. 1998). On the basis
of the requirements for RAD53 and MEC1, it may be
that S. cerevisiae cells need to actively inhibit progression through the cell cycle until the end of DNA replication in most cell cycles. In contrast, the homologs
found in Schizosaccharomyces pombe, CDS1 and RAD3, respectively, are not required for viability ( Jimenez et al.
1992; Seaton et al. 1992; Murakami and Okayama
1995; Bentley et al. 1996).
Here we report that the essential requirement for
MEC1 can be suppressed by deletion of the G1 cyclins
CLN1 and CLN2. mec1-1 and mec1D mutant cells deleted
for cln1 and cln2 are killed by expression of CLN1, CLN2,
or CLB5, but not by CLN3, from the strong, inducible
GAL1 promoter. Wild-type levels of either CLN1 or CLN2
also cause severe growth defects in mec1-1 strain; the
presence of wild-type levels of both CLN1 and CLN2 in
mec1-1 strains may be lethal, consistent with previously

reported results (Paulovich et al. 1997; Zhao et al.
1998). Isolation and characterization of multicopy suppressors of the mec1-1 GAL1-CLN1 lethality suggests that
deoxyribonucleotide pools may be limiting during replication, with lethal consequences to mec1 mutant strains
that cannot pause the cell cycle.

MATERIALS AND METHODS
Strains and media: Media and genetic methods are as described elsewhere (Ausubel et al. 1987; Rose et al. 1990). The
strains used in this study are listed in Table 1. All yeast strains
were isogenic with BF264-15D (trp1-1a leu2-3,112 ura3 ade1
his2) unless otherwise noted. Mutant cln1, cln2, and cln3 alleles,
and the GAL1-CLN1, GAL1-CLN2, GAL1-CLN3, GAL1-CLB5
cassettes have been described previously (Richardson et al.
1989; Cross 1990; Cross and Tinkelenberg 1991; Epstein
1992; Cross and Blake 1993; Oehlen and Cross 1994). The
mec1-1 allele (Weinert et al. 1994), rad53::HIS3 disruption
(Zheng et al. 1993), and tel1::URA3 disruption (Greenwell
et al. 1995) were backcrossed multiple times to BF264-15D
strains as indicated in the strain list. The mec1-1 mutant spores
in the fifth and sixth backcrosses were uniform in size, and
spore viability in the 48 tetrads analyzed in the fifth backcross
was 86% for both the mec1-1 and MEC1 spores. In the 48
tetrads examined in the sixth backcross, the spore viability
was 94% for the mec1-1 spores and 95% for MEC1 spores.
Similarly, strains containing the tel1 deletion allele were uniform in size, and viability of the tel1 spores was 98% in the 48
tetrads analyzed in the fourth backcross.
A disruption of mec1, referred to as mec1D, deleting all but
the first 98 and last 124 nucleotides of the 7107-nucleotide
MEC1 gene and inserting URA3, was constructed and integrated into a cln1 cln2 diploid strain in the BF264-15D background (R. Gardner and T. Weinert, personal communication). Spores from the diploid were analyzed; the viability for
mec1D spores was 100% in the 23 tetrads analyzed. The URA3
marker disrupting mec1 was swapped to LEU2 or TRP1 (Cross
1997) before transformation with URA3 plasmids. A disruption
of sic1 (the gift of M. Mendenhall) was also integrated into
cln1 cln2 diploid strains in the BF264-15D background.
The rad53 mutant spores were kept covered by the checkpoint defective spk1-1 allele of rad53 on a plasmid that was
the gift of D. Stern (Fay et al. 1997). Those rad53::HIS3 mutant
spores that did not contain the spk1-1 plasmid were uniform
in size, although much smaller than wild-type RAD53 spores
or rad53::HIS3 spores containing the spk1-1 plasmid.
For all analyses using mec1-1, mec1D, rad53::HIS3, and
tel1::URA3, a few different strains were examined for all phenotypes and they always behaved similarly. Representative experiments are shown.
Hydroxyurea (Sigma Chemical, St. Louis) was used in solid
media at 0.2 m.
Plating efficiency assays: Tenfold serial dilutions in water
were made from fresh stationary-phase cultures, and 5 ml from
each dilution was plated. Plates were incubated for 2–4 days
at 308.
Northern (RNA) analysis: RNA was isolated, probes were
labeled, and Northern blots were performed as described elsewhere (McKinney et al. 1993; Oehlen and Cross 1994).
Quantification of mRNA was performed by using a Molecular
Dynamics (Sunnyvale, CA) phosphorimager and ImageQuant
software, and mRNA loading was normalized by using TCM1
as a loading control. Probe fragments CLN1, CLN2, UBI4,
H2A, and CLB5 are as described elsewhere (Cross and Tinkelenberg 1991; Epstein and Cross 1992; Kiser and Wein-
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TABLE 1
Yeast strains
Strain
RGY48UT1
0015 2C
0016 2D
0016 18B
0016 19D
0018 4D
0018 8B
0018 11B
0020 1B
0020 3A
0020 3D
0020 5C
0020 7D
0020 11D
1227 2C
1238 11A
1238 16B
1255 5C-1
2507 5B
2507 5D
2618 5B
2619 1B
2620 12C
2623 11D
2662 20C
2665 13A
2670 2D
2670 8A
2671 5A
2671 5B
2671 11B
2673 4C
2673 5C
2673 6A
2673 6C
2673 8A
2673 9C
2687 26D
2687 28C
2687 30A
2687 30B
2687 34A
2688 26A

Genotype
MATa/a cln1/cln1 cln2/cln2 CLN3/CLN3 leu2/leu2::GAL1-CLN1::LEU2 MEC1/mec1D::ura3::TRP1
MATa cln1 cln2 CLN3 mec1D::ura3::TRP1
cln1 cln2 CLN3 mec1-1 tel1::LEU2 GAL-CLN2 multicopy RNR1
cln1 cln2 CLN3 mec1-1 tel1::LEU2 GAL-CLN2 multicopy RNR1
cln1 cln2 CLN3 mec1-1 tel1::LEU2 multicopy RNR1
cln1 cln2 CLN3 mec1-1 tel1::LEU2 YEp24
cln1 cln2 CLN3 mec1-1 tel1::LEU2 GAL-CLN2 YEp24
cln1 cln2 CLN3 mec1-1 tel1::LEU2 GAL-CLN2 YEp24
MATa cln1 cln2 mec1D::ura3::TRP1 tel1::URA3
MATa cln1 cln2 mec1D::ura3::TRP1 leu2:GAL1-CLN1::LEU2
MATa cln1 cln2 mec1D::ura3::TRP1 tel1:URA3
MATa cln1 cln2 mec1D::ura3::TRP1 tel1:URA3 leu2:GAL1-CLN1::LEU2
MATa cln1 cln2 mec1D::ura3::TRP1 tel1:URA3 leu2:GAL1-CLN1::LEU2
MATa cln1 cln2 mec1D::ura3::TRP1
MATa cln1 CLN2 cln3
MATa cln1 cln2 CLN3 bar1
MATa cln1 cln2 CLN3
MATa CLN1 CLN2 CLN3 bar1 HIS2
MATa cln1 cln2 CLN3 leu2::GAL1-CLN1::LEU2
MATa cln1 cln2 CLN3
MATa cln1 cln2 CLN3 mec1-1(53 backcross)
MATa cln1 cln2 CLN3 mec1-1 leu2::GAL1-CLN1::LEU2 (53 backcross)
MATa cln1 cln2 CLN3 mec1-1(53 backcross)
MATa cln1 cln2 CLN3 mec1-1 leu2::GAL1-CLN1::LEU2 (53 backcross)
MATa cln1 cln2 CLN3 mec1-1 leu2::GAL1-CLN1::LEU2 his3 (63 backcross)
MATa cln1 cln2 CLN3 mec1-1 trp1::GAL1-CLN2::TRP1 (63 backcross)
MATa cln1 cln2 CLN3 mec1-1 leu2::GAL1-CLN3::LEU2 (63 backcross)
MATa cln1 cln2 CLN3 leu2::GAL1-CLN3::LEU2
MATa cln1 cln2 CLN3 mec1-1 (63 backcross)
MATa cln1 cln2 CLN3 leu2::GAL1-CLN2::LEU2
MATa cln1 cln2 CLN3 mec1-1 leu2::GAL1-CLN2::LEU2 (63 backcross)
MATa cln1 cln2 CLN3 leu2::GAL1-CLN1::LEU2 HIS2 his3
MATa cln1 cln2 CLN3 HIS2 his3
MATa cln1 cln2 CLN3 rad53::HIS3 HIS2 his3 (43 backcross)
MATa cln1 cln2 CLN3 rad53::HIS3 leu2::GAL1-CLN1::LEU2 HIS2 his3 (43 backcross)
MATa cln1 cln2 CLN3 rad53::HIS3 leu2::GAL1-CLN1::LEU2 HIS2 his3 (43 backcross)
MATa cln1 cln2 CLN3 rad53::HIS3 HIS2 his3 (43 backcross)
MATa cln1 cln2 CLN3 rad53::HIS3 leu2::GAL1-CLN1::LEU2 HIS2 his3 (53 backcross)
MATa cln1 cln2 CLN3 RAD53 leu2::GAL1-CLN1::LEU2 HIS2 his3 multicopy RNR1
MATa cln1 cln2 CLN3 rad53::HIS3 HIS2 his3 multicopy RNR1 (53 backcross)
MATa cln1 cln2 CLN3 rad53::HIS3 leu2::GAL1-CLN1::LEU2 HIS2 his3 multicopy RNR1 (53 backcross)
MATa cln1 cln2 CLN3 rad53::HIS3 HIS2 his3 rad53 (53 backcross)
MATa cln1 cln2 CLN3 RAD53 HIS2 his3 multicopy RNR1

All yeast strains were isogenic with BF264–15D (trp1-1 leu2-3,112 ura3 ade1 his2) and are bar1 unless otherwise noted. The
rad53 and mec1-1 mutations were backcrossed the indicated number of times into this background. Some strains were made HIS2
by transformation; the his3 allele was brought into the BF264–15D background by .11 backcrosses.
ert 1996). The RNR1 probe was a 2.3-kb BstEII-XbaI fragment
purified from LB77, a plasmid from the YEp24 genomic library
(Carlson and Botstein 1982) isolated in the course of this
work as described below. The RNR3 probe was made by PCR
amplification of a 1300-bp fragment using primers of the sequence CTGCAAGCTATAATTTCGAGAG and GGTCTTAA
TACATACTAACG.
Isolation and characterization of multicopy plasmid suppressors of GAL1-CLN1 mec1-1: Strain 2619 1B (mec1-1 GAL1CLN1) was transformed with a YEp24 genomic library (Carlson and Botstein 1982). Transformants were screened for
their ability to grow on SCGal-Ura plates. Putative Gal1 colo-

nies were picked from SCDex-Ura plates, purified, and retested. Plasmids were recovered from Gal1 strains (Hoffman
and Winston 1987) and plasmid linkage of the Gal1 phenotype was tested after retransformation. Plasmids were analyzed
by restriction mapping and Southern blotting.
For the RNR1-containing plasmids, the region required for
suppression was identified by the isolation and analysis of
transposon insertions into the plasmid (Huisman et al. 1987).
The ends of the genomic DNA insert were sequenced using
primers complementary to the region flanking the BamHI site
in YEp24. The location of transposon insertion was determined by restriction digestion analysis and sequence analysis
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Figure 1.—mec1 mutant cells die when CLN1, CLN2, or
CLB5 is overexpressed. Strains 2507 5D (cln1 cln2 MEC1), 2620
12C (cln1 cln2 mec1-1), and 218UL-9 (cln1 cln2 mec1D) were
transformed with the indicated CEN-based plasmids. Colonies
were picked and grown to stationary phase in selective media
containing 2% dextrose. Tenfold serial dilutions were made
from fresh stationary phase cultures of the strains indicated.
Five microliter volumes were plated and incubated for 3–4
days at 308. Dex, dextrose (glucose); Gal, galactose.

from primers complementary to the transposon ends. Dideoxy
sequencing with Sequenase 2.0 (United States Biochemical,
Cleveland) was performed according to the manufacturer’s
instructions). Sequences were then compared to the genomic
DNA sequences in the S. cerevisiae database using a BLAST
search (http://genome-www2.stanford.edu:5555/cgi-bin/nphblastsgd/).

RESULTS

Lethality of mec1-1 and CLN1, CLN2, and CLB5 overexpression: We have shown previously that mec1-1 cln1 cln2
strains are viable and are killed when GAL1-CLN1 is
expressed (Vallen and Cross 1995; see also Figure 1).
Expression of GAL1-CLN2, and to a somewhat lesser
extent, GAL1-CLB5, is also lethal to cln1 cln2 mec1-1
mutant cells (Figure 1). In all cases, there is about a
1000- to 10,000-fold decrease in plating efficiency of
strains containing GAL1-CLN1, GAL1-CLN2, or GAL1CLB5 compared to control mec1-1 mutant strains transformed with vector on galactose-containing media. Similar results were seen with strains containing a deletion
of MEC1 (Figure 1). Overexpression of CLN1, CLN2, or
CLB5 had no effect on the plating efficiency of the
MEC1 strains. In contrast to the results with CLN1, CLN2,
and CLB5, overexpression of CLN3 or the dominant
activating allele of CLN3, CLN3-2, from the GAL1 pro-

Figure 2.—(A) mec1 cln1 cln2 mutant cells are viable. Spores
from a diploid strain (RGY48UT1) formed by disruption of
mec1D in a cln1 cln2 homozygous diploid were dissected and
incubated at 308 for 3 days. The mec1D genotype was assigned
to spores on the basis of testing for hydroxyurea sensitivity
and scoring the TRP1 marker used to mark the mec1D allele.
The MEC1 genotype of each spore colony is noted below the
tetrad plates (D, mec1D; 1, MEC1). (B) Wild-type levels of
CLN1 and CLN2 cause slow growth of mec1-1 mutant cells.
Spores from a diploid strain formed by crossing CLN1 CLN2
CLN3 MEC1 (1255 5C-1) and cln1 cln2 CLN3 mec1-1 (2662
20C) were dissected and incubated at 308 for 3 days. The
mec1-1 genotype was assigned to spores on the basis of testing
for hydroxyurea sensitivity. The CLN1 and CLN2 genotypes
were assigned by Northern blot analysis. The mec1 genotype
of each spore colony is noted below the tetrad plates (2,
mec1-1; 1, MEC1).

moter does not kill the mec1-1 or mec1D strains (Figure
1 and data not shown). Colonies grow up slightly more
slowly than the vector controls, but the plating efficiency
of transformants is similar in the presence and absence
of CLN3 overexpression and comparable to that of the
control strains with no GAL1-CLN construct. In addition,
it is critical to point out that there are no obvious differences between the mec1-1 cln1 cln2 CLN3, mec1D cln1
cln2 CLN3, and MEC1 cln1 cln2 CLN3 strains on galactose
media when strains are transformed with the vector, or
between any of the strains on dextrose where the CLNs
are not overexpressed (Figures 1 and 2A). mec1-1 cln1
cln2 and MEC1 cln1 cln2 strains also had similar doubling
times in liquid media as measured by the optical density
of logarithmically growing cultures (T. Brenner and E.
Vallen, unpublished results). In contrast to the results
with CLN1, CLN2, and CLB5, GAL1-CLB2 slowed cell
growth and decreased plating efficiency similarly in both
MEC1 and mec1-1 strains (data not shown).

Checkpoints and G1 Cyclin Function
TABLE 2
The mec1-1 mutation causes a growth defect in strains
containing CLN1 and/or CLN2
Relevant genotype
mec1-1
mec1-1
mec1-1
mec1-1
mec1-1

cln1 cln2 CLN3
CLN1 cln2 cln3
CLN1 cln2 CLN3
cln1 CLN2 cln3
cln1 CLN2 CLN3

Fast growing

Slow growing

16
0
0
0
0

1
9
6
6
3

Spores from a diploid strain formed by crossing either
CLN1 cln2 cln3 MEC1 (1239 18A) or cln1 CLN2 cln3 MEC1
(1227 2C) and cln1 cln2 CLN3 mec1-1 (2623 11D) were dissected and incubated at 308 for 3 days. Fast growing and slow
growing refer to spore colony size as can be seen in Figure
1B. The mec1-1 genotype was assigned to spores on the basis
of testing for hydroxyurea sensitivity. The CLN1 and CLN2
genotypes were assigned by Northern blot analysis.

To examine the phenotype of mec1-1 cells with wildtype levels of the G1 cyclins, we crossed mec1-1 cln1 cln2
CLN3 strains to MEC1 CLN1 CLN2 CLN3 strains (Figure
2). In crosses when mec1-1 or mec1D was segregating in
a cln1 cln2 CLN3 background, it was difficult to distinguish the mec1 mutant spore colonies by colony size
(Figure 2A and data not shown). Some colonies in the
cross between the mec1 cln1 cln2 CLN3 and MEC1 cln1
cln2 CLN3 strains were slightly smaller than others but
this did not correlate with the MEC1 genotype (Figure
2A). These spores were usually MATa, and the slight
growth defect may be due to the fact that the strains
are bar12 and are therefore very sensitive to mating
pheromone.
In contrast to the fairly homogenous colony size in
the crosses when cln1 and cln2 were homozygous, in
crosses when mec1-1 and CLN1 and CLN2 were segregating, many of the spore colonies ranged in size from
small to tiny (Figure 2B). When tetrads from the CLN1
CLN2 CLN3 cross were scored for mec1-1 by HU sensitivity, the small and tiny colonies were always HU sensitive,
demonstrating that they contained mec1-1. A subset of
the colonies was scored for the presence of CLN1 and
CLN2 by Northern blotting. In 7/7 cases when the
mec1-1 strains were scored as fast growing (1D, 5A, 11C,
11D, 14D, 20D, 23D), the spore was cln1 cln2 CLN3.
Furthermore, in 6/7 cases when the mec1-1 strains were
scored as slow growing (3B, 9C, 10D, 15B, 22B, 24D),
the spore was CLN1 cln2 CLN3 or cln1 CLN2 CLN3. In
1/7 cases, the slow-growing spore was CLN1 CLN2 CLN3
(19C).
As all spores described in the crosses above were
CLN3, we wished to determine whether the slow-growth
phenotype observed with some mec1-1 spore colonies
was due to an increase in cyclin dosage or specifically
due to the presence of CLN1 or CLN2. We crossed CLN1
cln2 cln3 MEC1 strains with cln1 cln2 CLN3 mec1-1 strains
and, similarly, crossed cln1 CLN2 cln3 MEC1 with cln1
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cln2 CLN3 mec1-1 strains. Spore colonies were scored
for size, HU sensitivity, and CLN genes as described
above. In almost every case, small colony size correlated
with the presence of CLN1 or CLN2 and the mec1-1
mutation (Table 2). Strains that had CLN3 in addition
to CLN1 or CLN2 did not give significantly different
colony sizes than those strains that had only CLN1 or
CLN2.
These results demonstrate that MEC1 is required for
normal growth rates in cells with wild-type levels of CLN1
and/or CLN2 and that its essential function can be suppressed by deletion of CLN1 and CLN2. Although MEC1
was originally reported to be necessary only in cells
suffering from DNA damage (Weinert et al. 1994),
these data demonstrate that MEC1 is essential for normal growth of CLN cells. This is consistent with the
observations of Paulovich et al. (1997) and Zhao et al.
(1998) suggesting that mec1-1 mutant strains are inviable
in the A364a background in the absence of the suppressor locus sml1. Here, in SML1 cells, the essential requirement for MEC1 function is suppressed by deletion of
CLN1 and CLN2. The requirement for MEC1 function in
the DNA damage checkpoint is not suppressed; strains
containing cln1 cln2 mec1-1 or cln1 cln2 mec1D are still
sensitive to HU.
To analyze the effects of increasing the amount of
CLB5 kinase activity on the mec1 mutant strains, crosses
between cln1 cln2 CLN3 mec1-1 and cln1 cln2 CLN3
sic1::URA3 strains were also examined. Deletion of the
cyclin B kinase inhibitor sic1 should result in increased
and earlier activity of B-type cyclins, including CLB5
(Schwob et al. 1994; Dirick et al. 1995). Tetrad analysis
demonstrated that the MEC1 SIC1, mec1-1 SIC1, and
MEC1 sic1 spore colonies were all similar in size. In
contrast, all 33 of the viable mec1-1 sic1 spore colonies
were significantly smaller than the other spore colonies
(data not shown), consistent with the decreased plating
efficiency of the mec1 cln1 cln2 GAL-CLB5 strains. The
viability of the sic1 mec1 double mutants was 79%, comparable to the viability of the sic1 single mutants (73%).
rad53 and mec1 tel1 mutants are not completely suppressed by loss of CLN1 and CLN2: On the basis of
genetic and biochemical data, it has been suggested
that MEC1 functions upstream of RAD53 and the kinase
activity of Mec1p is required to activate Rad53p (Kiser
and Weinert 1996; Sanchez et al. 1996; Sun et al. 1996).
RAD53 is an essential gene (Zheng et al. 1993). If
RAD53’s only role is transducing a signal from MEC1,
and loss of CLN1 and CLN2 suppress loss of MEC1, loss
of CLN1 and CLN2 should also suppress the essential
role of RAD53.
We backcrossed rad53::HIS3 strains against cln1 cln2
CLN3 strains multiple times. To cover the rad53 lethality,
the checkpoint-defective rad53 allele, spk1-1, was present
on a URA3-containing plasmid. In contrast to the results
seen with mec1, deletion of CLN1 and CLN2 did not
completely suppress the requirement for RAD53; all the
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spore colonies that were His1Ura2 (i.e., rad53::HIS3)
were significantly smaller than His2 or His1Ura1 spore
colonies. Cultures of the cln1 cln2 rad53 mutants grew
to about 1⁄10 the density of cln1 cln2 RAD53 strains in
rich liquid medium even after long times of incubation
at 308 (Figure 3A). When cells from these cultures were
plated on dextrose, the rad53::HIS3 strains formed colonies that were smaller than wild type. We assayed strains
containing GAL1-CLN1 rad53::HIS3 on galactose and
found that the presence of GAL1-CLN1 decreases plating efficiency less severely for them than it did for the
mec1 strains. There was an z10- to 100-fold decrease in
plating efficiency of rad53 GAL1-CLN1 strains compared
to rad53::HIS3 strains without GAL1-CLN1 (Figure 3A).
These results were obtained using rad53 strains that
had been backcrossed into the BF264-15D strain background four times; similar results were observed using
strains that had been additionally backcrossed into this
strain background (data not shown). Strains containing
rad53::HIS3 and the checkpoint-defective rad53 allele
spk1-1 on a plasmid were not killed by expression of
CLN1 from the GAL1 promoter (data not shown). As
the growth defect of the rad53 mutants was not fully
suppressed by cln1 cln2, as the growth defect is in the
mec1 mutants, it appears that rad53 has some MEC1independent functions.
TEL1 has homology to MEC1 and increased dosage
of TEL1 can suppress some mec1 mutant phenotypes
(Greenwell et al. 1995; Morrow et al. 1995). Rad53p
may function downstream of both Mec1p and Tel1p.
To determine if the rad53 phenotypes were similar to
the phenotypes observed with loss of MEC1 and TEL1,
we first generated cln1 cln2 tel1 strains. cln1 cln2 tel1
mutants displayed no growth defect and their plating
efficiency was not affected by overexpression of CLN1
or CLN2 (data not shown). We then crossed cln1 cln2
mec1-1 and cln1 cln2 tel1::URA3 strains and analyzed
spores resulting from the diploids. The spore viability
of the mec1-1 tel1 double mutants was high (93% in 95
tetrads), although the mec1 tel1 double mutant spore
colonies were always smaller than the other spore colonies. Like the rad53 mutants, the cln1 cln2 mec1 tel1
strains grew to about 1⁄10 to 1⁄100 the density of cln1 cln2
MEC1 or cln1 cln2 TEL1 cultures (Figure 3B and data
not shown). The lethality in the mec1 tel1 mutants caused
by expression of CLN1 or CLN2 from the GAL promoter
was similar to that seen with mec1 mutants alone and is
more severe than the lethality seen with the rad53 strains
(Figure 3B and data not shown). On the basis of these
data and previous genetic analysis, the simplest interpretation of the similar growth defects seen with cln1 cln2
rad53 and cln1 cln2 mec1 tel1 strains is that RAD53 functions downstream of both MEC1 and TEL1. The decreased viability seen with overexpression of CLN1 or
CLN2 in mec1 or mec1 tel1 strains compared to rad53
strains is consistent with previous observations that

Figure 3.—(A) rad53 mutant cells are only partly suppressed by cln1 cln2 and are less sensitive to GAL1-CLN1 expression than mec1 mutants. Tenfold serial dilutions were made
from fresh stationary phase cultures in YPD of strains with the
indicated genotypes (GAL-CLN1 cln1 cln2 RAD53; 2673 4C;
cln1 cln2 RAD53, 2673 5C; GAL-CLN1 cln1 cln2 rad53, 2673 6C
and 2673 8A; cln1 cln2 rad53, 2673 6A and 2673 9C). Five
microliter volumes were plated and incubated for 2–3 days at
308. DEX, dextrose (glucose); GAL, galactose. (B) mec1D tel1D
mutant cells have a growth defect and are sensitive to overexpression of CLN1. Tenfold serial dilutions were made from
fresh stationary phase cultures in YPD of strains with the indicated genotypes (cln1 cln2 mec1D TEL1, 0020 11D; GAL-CLN1
cln1 cln2 mec1D TEL1, 0020 3A; cln1 cln2 mec1D tel1D, 0020 1B
and 0020 3D; GAL-CLN1 cln1 cln2 mec1D tel1D, 0020 5C and
0020 7D. Five microliter volumes were plated and incubated
for 2–3 days at 308.

MEC1 has at least one RAD53-independent function
(Kiser and Weinert 1996).
Multicopy RNR1 suppresses the lethality of mec1 CLN1
and mec1 CLN2: To understand more completely the
cause of the inviability of mec1-1 GAL1-CLN1 strains,
we isolated multicopy plasmid suppressors of the lethal
phenotype. Transformants (17,000) from a YEp24 library (Carlson and Botstein 1982) were screened
for their ability to grow on galactose. The 13 strongest
suppressors fell into three groups by restriction analysis
and Southern blotting. Two plasmids contained MEC1
and eight plasmids contained TEL1. Both of these
classes were expected; the mec1-1 mutation is known to
be recessive to MEC1, and increased levels of TEL1 have
previously been shown to suppress other phenotypes
associated with the mec1-1 mutation (Morrow et al.
1995; Sanchez et al. 1996). The three remaining plasmids contained the RNR1 gene. Transposon mutagenesis (Huisman et al. 1987) of the plasmid demonstrated
that the suppression required an intact RNR1 gene.
Multicopy RNR1 suppressed the lethality of mec1-1
GAL1-CLN1 strains about 10003 compared to the vector
controls (data not shown). This was similar to the plating
efficiencies found with MEC1 plasmids; however, the
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Figure 4.—Suppression by multicopy RNR1. (A and B)
mec1-1 GAL1-CLN2 and mec1D GAL-CLN1 mutants are suppressed by multicopy RNR1. Strains 2665 13A (mec1-1 GAL1CLN2) and 0015 2C (mec1D GAL-CLN1) were transformed with
the indicated plasmids. Colonies were picked and grown to
stationary phase in selective media containing 2% dextrose.
Tenfold serial dilutions were made from fresh stationary phase
cultures and 5 ml volumes were plated and incubated for 3–4
days at 308. (C) Strains with the indicated genotypes (RAD53
GAL-CLN1 multicopy RNR1, 2687 28C; RAD53 multicopy
RNR1, 2688 26A; rad53 GAL-CLN1 multicopy RNR1, 2687 30B;
rad53 multicopy RNR1, 2687 30A; rad53 GAL-CLN1, 2687 26D;
rad53, 2687 34A) were recovered after sporulation of a diploid
containing the multicopy RNR1 plasmid and analyzed. Cells
were grown to stationary phase in YPD and 10-fold serial dilutions were made. Five microliter volumes were plated and
incubated for 3–4 days at 308. (D) Strains with the indicated
genotypes (mec1-1 tel1::LEU2 GAL-CLN2 YEp24, 0018 8B and
0018 11B; mec1-1 tel1::LEU2 GAL-CLN2 multicopy RNR1, 0016
2D and 0016 18B; mec1-1 tel1::LEU2 YEp24, 0018 4D; mec1-1
tel1::LEU2 multicopy RNR1, 0016 19D) were recovered after
sporulation of a diploid heterozygous for mec1-1 and tel1::LEU2
that contained the multicopy RNR1 plasmid. Cells were grown
and plated as described for A and B. DEX, dextrose (glucose);
GAL, galactose.

colony size of the mec1-1 GAL1-CLN1 strains with the
multicopy RNR1 plasmid was somewhat smaller at early
times of incubation than that of the mec1-1 GAL1-CLN1
strains with the MEC1 plasmid. The RNR1 plasmid also
suppressed the lethality caused by overexpression of
CLN2 (Figure 4A) or CLB5 (data not shown) in a mec1-1
strain. Similar results were seen with strains containing
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the mec1D allele, demonstrating that multicopy RNR1
bypasses the requirement for MEC1 function (Figure 4B).
To determine whether multicopy RNR1 could suppress the growth defects caused by wild-type levels of
CLN1 and CLN2 in a mec1 strain, mec1-1 cln1 cln2 CLN3
strains were crossed to MEC1 CLN1 CLN2 CLN3 strains
containing the multicopy RNR1 plasmid. Diploids were
sporulated and tetrads were dissected and scored as
described above. Thirteen spores that were mec1-1 and
contained the RNR1 plasmid were recovered. All spores
containing the RNR1 plasmid formed colonies similar
in size to the MEC1 spores; seven of the colonies were
CLN1 and/or CLN2. Furthermore, spore colonies that
were cln1 cln2 mec1-1 were able to lose the URA3-based
RNR1 plasmid as determined by their ability to grow
on media containing 5-FOA while colonies that were
mec1-1 CLN1 and/or CLN2 were unable to lose the plasmid. Taken together, this demonstrates that increased
RNR1 dosage can suppress the growth defect caused by
CLN1 and CLN2 in a mec1 mutant strain and suggests
that the defect caused by overexpression of CLN1 or
CLN2 is qualitatively similar to that caused by wild-type
levels of G1 cyclin dosage in a mec1 mutant strain.
To determine whether the multicopy RNR1 plasmid
could suppress the growth defect caused by deletion of
rad53, a cln1 cln2 CLN3 rad53::HIS3 strain containing
the URA3-based spk1-1 plasmid was crossed to a cln1 cln2
CLN3 RAD53 strain. Diploids that had lost the spk1-1
plasmid were transformed with the multicopy URA3based RNR1 plasmid and sporulated, and the resulting
tetrads were dissected. Tetrads contained two large His2
colonies and zero, one, or two very small His1 colonies.
Increased RNR1 dosage did not affect the colony size;
Ura1 His1 (RNR1-containing; rad53) and Ura2 His1
(rad53) colonies appeared similarly small on the tetrad
dissection plate (data not shown). However, quantitative
plating efficiencies showed that cln1 cln2 rad53 strains
containing the multicopy RNR1 plasmid grew to higher
densities in liquid culture than similar strains lacking
the plasmid, although they did not reach the density
achieved by RAD53 strains. When rad53 mutants containing GAL-CLN1 were analyzed on galactose, the presence of the RNR1 plasmid suppressed the decrease in
viability associated with overexpression of CLN1 in the
rad53 strains (Figure 4C). The ability of multicopy RNR1
to suppress the lethality caused by overexpression of
CLN1 in both mec1 and rad53 mutant strains is consistent
with the lethality being caused by a similar mechanism in
both cases. Furthermore, this experiment demonstrates
that RAD53 function is not likely to be required for
RNR1’s suppression of mec1 GAL-CLN1 lethality.
To determine whether the multicopy RNR1 plasmid
could suppress the growth defect caused by mec1 tel1, a
cln1 cln2 CLN3 tel1::LEU2 strain was crossed to a cln1
cln2 CLN3 mec1-1 strain. Diploids were transformed with
the multicopy URA3-based RNR1 plasmid and sporulated, and the resulting tetrads were dissected. Doubly
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mutant mec1 tel1 spore colonies were smaller than the
singly mutant or wild-type colonies. As described above
for rad53 strains, increased RNR1 dosage did not appear
to affect the colony size; Ura1 (RNR1-containing) and
Ura2 mec1 tel1 colonies appeared similar in size (data
not shown). However, quantitative plating efficiencies
showed that, similar to rad53 strains, cln1 cln2 mec1 tel1
strains containing the multicopy RNR1 plasmid grew to
higher densities in liquid culture than similar strains
lacking the plasmid. When mec1 tel1 mutants containing
GAL-CLN2 were analyzed on galactose, the presence of
the RNR1 plasmid suppressed the decrease in viability
associated with overexpression of CLN2 (Figure 4D).
This demonstrates that suppression of mec1 GAL-CLN2
by multicopy RNR1 does not depend on TEL1 function.
However, the persistent growth defect seen in rad53 and
mec1 tel1 strains even in the presence of increased RNR1
demonstrates that it is unlikely that the observed growth
defects are due to limiting nucleotide levels.
One way to suppress the mec1 GAL-CLN1 and GALCLN2 synthetic lethality might be inhibition of passage
through the G1 to S phase transition (START). We
consider this explanation unlikely for RNR1’s ability to
suppress for a few reasons. First, inhibition of passage
through START is not consistent with the known function of ribonucleotide reductase. Second, if RNR1 were

inhibiting passage through START, there should be an
accumulation of cells with 1N DNA content. Using FACS
analysis, we analyzed the cell cycle distribution of logarithmically growing cells containing GAL-CLN1, GALCLN2, or GAL-CLN3 and either a multicopy RNR1 plasmid or a multicopy plasmid with RNR1 disrupted with
a transposon insertion. No difference in the cell cycle
distribution of these strains was observed (data not
shown). Third, if RNR1 were inhibiting passage through
START without affecting cell growth, cell size would be
expected to increase (Cross et al. 1989). Analysis of cell
volume [using a Coulter Channelyzer (Coulter Corp.,
Hialeah, FL)] demonstrated that cells containing the
RNR1 plasmid were no bigger than cells found in the
vector controls (data not shown). Taken together, these
data suggest that it is unlikely that increased RNR1 function is simply inhibiting passage through START.
RNR1 transcription levels are decreased in GAL1CLN1 and GAL1-CLN2 strains: As multicopy RNR1 suppressed the lethality of the mec1-1 GAL1-CLN1 and GAL1CLN2 strains, we analyzed the levels of RNR1 transcript
in these strains. Levels of RNR1 are about threefold
lower in mec1-1 GAL1-CLN1 or mec1-1 GAL1-CLN2 strains
than in mec1-1 with vector controls (Figure 5, A and B).
A similar decrease in RNR1 transcription was found in
MEC1 GAL1-CLN1 and MEC1 GAL1-CLN2 strains, dem-

Figure 5.—Transcriptional regulation of
MCB-containing genes RNR1 and CLB5 and of
H2A. cln1 cln2 CLN3 MEC1 and cln1 cln2 CLN3
mec1-1 strains with the indicated GAL1-CLN
construct were grown to log phase in YEP-3%
raffinose at 308. At time 0, galactose was added
to the cultures to a final concentration of 3%.
Samples were taken at 2-hr intervals and RNA
was isolated. Blots were hybridized with RNR1
(A and B), CLB5 (C and D), H2A (E and F),
and TCM1 (used as a loading control). Quantification of mRNA was performed using a Molecular Dynamics phosphorimager and ImageQuant software. Data from two different
experiments are shown; Northern blots were
prepared and analyzed from samples five times
with equivalent results. (A, C, and E) MEC1,
open squares (1238 16B); MEC1 GAL-CLN1,
solid squares (2507 5B); mec1-1, open circles
(2618 5B); mec1-1 GAL-CLN1, solid circles
(2623 11D). (B, D, and F) MEC1, open squares
(1238 16B); MEC1 GAL-CLN2, solid squares
(2671 5B); MEC1 GAL-CLN3, hatched squares
(2670 8A); mec1-1, open circles (2671 5A);
mec1-1 GAL-CLN2, solid circles (2671 11B);
mec1-1 GAL-CLN3, hatched circles (2670 2D).
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onstrating that the decrease in RNR1 levels was not due
to the mec1-1 mutation (Figure 5, A and B). The decrease
in RNR1 transcription was evident in both MEC1 and
mec1-1 cells, but has lethal consequences only in the
mec1-1 mutants. GAL1-CLN3 decreased transcription of
RNR1 to a level intermediate between that of GAL1CLN1 or GAL1-CLN2 and the vector control (Figure 5B).
RNR1 transcription has been previously shown to be
cell cycle regulated (Elledge and Davis 1990) and the
coding sequence is preceded by four MCB elements
within the 500 nucleotides upstream of the AUG that
starts the protein-coding region. To determine whether
GAL1-CLN1 and GAL1-CLN2 affected other MCB-regulated genes, we analyzed the transcript levels of another
MCB-containing gene, the B-type cyclin CLB5. CLB5
levels also decreased as a consequence of GAL1-CLN1
and GAL1-CLN2 expression (Figure 5, C and D). It is
likely that the decrease in RNR1 and CLB5 RNA levels
seen upon induction of the CLN genes is due to a change
in the amount of active MBF present in the population
or to an alteration in the distribution of cells in the
cell cycle, not to direct repression of RNR1 and CLB5
transcription.
To determine whether the transcription of other
genes was also affected, we analyzed the expression of
the histone H2A. In contrast to the results seen with
the MCB-regulated CLB5 and RNR1 transcripts, H2A
mRNA was not affected by the expression of CLN1 or
CLN2 (Figure 5, E and F). H2A transcripts peak about
0.1 cell cycle units after the MCB-regulated genes and
are subject to a different pathway of regulation (White
et al. 1987). Although histone transcription is cell-cycle
regulated, the steady-state levels of histone transcripts
appear to be tightly coupled to the ongoing rate of DNA
replication (Osley 1991; Muller 1994). The observation that H2A transcript levels do not decrease upon
CLN overexpression suggests that DNA replication and
cell division are occurring similarly in all strains.
Because RNR1 is also regulated by DNA damage
(Elledge and Davis 1990), we wished to determine
whether high levels of expression of the CLN genes from
the GAL1 promoter affected DNA-damage-inducible
genes. We analyzed the levels of two damage-inducible
genes, RNR3 and UBI4, in mec1-1 and MEC1 strains containing GAL1-CLN constructs. DNA damage induces
RNR3 transcription in a MEC1-dependent pathway and
UBI4 transcription in a MEC1-independent pathway
(Kiser and Weinert 1996). The levels of these transcripts were not altered upon GAL1-CLN expression
(data not shown). This demonstrates that high levels of
CLN expression do not induce a DNA-damage response.
DISCUSSION

MEC1 is required in unperturbed wild-type cells, but
not in cln1 cln2 cells: Although the mec1-1 mutation was
originally identified as causing lethality specifically when
DNA damage was induced or replication slowed (Wein-
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ert et al. 1994), our results clearly show that MEC1
is required in normally cycling wild-type cells. This is
consistent with the observation that a suppressor locus,
sml1, was present in the previously characterized mec1-1
strains (T. Weinert, personal communication; Paulovich et al. 1997; Zhao et al. 1998). However, we showed
previously (Vallen and Cross 1995) and confirm here
that in a cln1 cln2 background, no additional suppressor
in our strain background is required for full viability
and wild-type growth of mec1-1 strains.
Mec1p has been shown to be required for slowing of
S phase in response to DNA damage (Paulovich and
Hartwell 1995). The present results therefore suggest
that some Mec1-dependent slowing of S phase may be
required even in unperturbed wild-type cell cycles, but
that this slowing is not required in cln1 cln2 strains. In
contrast to the case with S. cerevisiae, the S. pombe MEC1
homolog, rad3, is not essential. One possibility is that
because the two yeasts regulate their size control in
different stages of the cell cycle (G1 for S. cerevisiae,
G2 for S. pombe), they have different requirements for
DNA synthesis checkpoints in unperturbed cell cycles
(Elledge 1996). Consistent with this argument, wee1
mutant fission yeast, which converts from a G2/M to a
G1/S size control (Fantes and Nurse 1978), requires
rad3 for viability (Al-Khodairy and Carr 1992). It may
be that in both yeasts, MEC1/rad3 is required to ensure
that there is sufficient time to prepare for and execute
DNA synthesis but that this requirement is cryptic in S.
pombe because the time spent in G2 usually results in
adequate growth for the following S phase (Elledge
1996). The Mec1p requirement for the DNA replication
checkpoint induced by hydroxyurea treatment is separate temporally from the cell cycle function and is not
bypassed in cln1 cln2 strains, as cln1 cln2 mec1-1 strains
are sensitive to hydroxyurea inhibition of DNA synthesis.
Therefore, we conclude that deletion of CLN1 and CLN2
eliminates the Mec1p requirement specifically in the
unperturbed cell cycle.
Rad53p cannot function solely downstream of Mec1p:
RAD53 is an essential gene that has been proposed to
function in the same pathway as MEC1. Analysis of
the transcriptional induction of DNA-damage-inducible
genes suggests that MEC1 is upstream of RAD53 because
it affects the transcription of more genes (Kiser and
Weinert 1996). However, cln1 cln2 rad53 strains are
inviable or else form tiny colonies in tetrad analysis, in
contrast to the large colonies formed by cln1 cln2 mec1-1
and cln1 cln2 mec1D strains. In addition, when spk1-1, a
checkpoint-deficient allele of RAD53, is used, full viability is observed, and CLN1 overexpression does not affect
this viability. These data suggest that Rad53p has at least
one function that is not wholly dependent on Mec1p.
It is likely that TEL1 modulates the MEC1-independent activity of RAD53. TEL1 and MEC1 are 48% similar
and it has been shown that they have some overlap in
function (Greenwell et al. 1995; Morrow et al. 1995).
cln1 cln2 cells deleted for both MEC1 and TEL1 have a
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growth defect that appears similar to that of cln1 cln2
rad53 cells. Other work has also suggested that RAD53
may have some roles that are MEC1-independent as
temperature-sensitive defects in a component of the
replication factor C complex, rfc5-1, can be suppressed
by increased expression of RAD53 and TEL1, but not
by MEC1 (Sugimoto et al. 1997). Furthermore, the ability of RAD53 overexpression to suppress the rfc5-1 defect
is dependent on TEL1 function (Sugimoto et al. 1997).
Additional evidence that RAD53 may have MEC1-independent functions is that rad53 rad16 double mutants
show increased sensitivity to UV irradiation compared
to either single mutant, while mec1 rad16 double mutants
do not show this synthetic phenotype (Kiser and Weinert 1996). Although interpretation of the UV sensitivity
is complicated by the fact that the mec1 and rad53 mutations analyzed were point mutations, rather than null
alleles, and also that the sml1 suppressor may be present
only in the mec1 mutant strains, these data, as well as
the data presented here, are consistent with the model
that Rad53p is regulated by proteins in addition to
Mec1p, such as Tel1p.
One difference between the rad53 and mec1 tel1 strains
is their response to overexpression of CLNs; the growth
defect in the rad53 strains is not as exacerbated by CLN1
or CLN2 overexpression as the mec1 or mec1 tel1 mutant
strains. MEC1 and TEL1 likely have some activity that is
not mediated through RAD53. It is known, for example,
that MEC1 is required for the transcriptional activation
of some genes that do not require RAD53 (Kiser and
Weinert 1996).
CLN1 and CLN2 function may lead to dNTP limitation
and a requirement for the Mec1 checkpoint: cln1 cln2
mec1-1 strains overexpressing Cln1p (from the GAL1CLN1 construct) are inviable (Vallen and Cross 1995).
RNR1, encoding the limiting subunit of ribonucleotide
reductase, is an efficient high-copy plasmid suppressor
of this inviability. We found that overexpression of either CLN1 or CLN2 lowered RNR1 expression (similarly
in mec1-1 and MEC1 backgrounds). These results combined to lead us to the following hypothesis to explain
mec1 GAL1-CLN1 lethality: if CLN1 expression results in
entry into S phase before a sufficient period for accumulation of Rnr1p, cells may enter S phase with inadequate
dNTP pools. If this happens in a MEC1 background,
this should result in the characterized Mec1-dependent
slowing of S phase, consistent with full viability; but in
a mec1 background this slowing of S phase would not
occur, leading to mitosis without completion of replication and inviability of progeny. We showed previously
that in diploid cells of the genotype mec1-1 GAL-CLN1,
rare survivors showed signatures of DNA damage: 100fold elevated chromosome loss and recombination frequencies, as would be expected from this hypothesis
(Vallen and Cross 1995). The most likely explanation
for the ability of multicopy RNR1 to suppress the essential requirement for MEC1 is that cells require MEC1 to

inhibit or slow S phase until adequate pools of dNTPs
have accumulated. Overexpression of RNR1 would be
expected to increase the levels of dNTPs and might
allow S phase to begin earlier or proceed more quickly.
It has been previously reported that cell cycle length
or doubling time does not change much in the presence
of overexpressed CLN genes, but much less of the cell
cycle is taken up by G1 because cells go through START
at a smaller size (Cross 1988; Nash et al. 1988). Because doubling time is constant, the cells must be delayed at some other cell cycle stage. It may be that cells
containing GAL-CLN1 or GAL-CLN2 are delayed in S
phase in a MEC1-dependent fashion. We attempted to
perform execution point experiments to determine the
length of S phase in wild-type cells and cells overexpressing the G1 cyclins; while the data suggested that
CLN1 overexpression prolonged S phase, variability between strains in this analysis prevents drawing definitive
conclusions from these experiments. Additionally, because mec1 mutant cells fail to arrest in HU, it is not
possible to measure the length of S phase in mec1 strains
by this method. Another prediction of the model is that
GAL1-CLN1 strains containing multicopy RNR1 would
have a shorter S phase. Although FACS analysis of cells
containing the high-copy RNR1 plasmid demonstrated
that the plasmid does not appear to affect the cell cycle
distribution of strains, because of the breadth of the 1N
and 2N peaks, and because the number of cells that are
in S phase is small, it is impossible to tell whether the
number of cells in S phase is reduced by this analysis.
A surprising consequence of the hypothesis that cells
frequently enter S phase with inadequate dNTP pools,
combined with the observation of semilethality or lethality of CLN1 CLN2 CLN3 mec1-1 strains, is that preparation for DNA replication, including dNTP accumulation, in wild-type cells may be barely adequate for
completion of S phase, resulting in a significant requirement for Mec1 function to restrain the rate of S phase
progression. Wild-type cells may operate according to
a “just-in-time” principle, i.e., transit through START
and entry into S phase may occur when there are usually
just adequate materials for DNA replication. This would
be highly efficient because it allows cells to enter the
cell cycle with a minimum of preparatory time, thus
giving rise to more progeny, but it could impose a requirement for safeguards in case of shortages.
Deletion of CLN1 and CLN2 may result in an unbalanced cell cycle with excess time for preparation for
DNA synthesis, suppressing the Mec1 requirement:
Cln3p has been proposed to be specialized for transcriptional activation of SCB- and MCB-regulated genes at
the G1-S border; RNR1 is one such gene (Tyers et al.
1993; Koch and Nasmyth 1994; Dirick et al. 1995;
Stuart and Wittenberg 1995; Levine et al. 1996).
Cln1 and Cln2, in contrast, directly trigger cell cycle
START, and lead to DNA replication (at least in part
by activation of Clb-Cdc28 kinase complexes; reviewed
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by Cross 1995; Nasmyth 1996). Thus in a cln1 cln2
background, a prolonged period of transcriptional activation of SCB- and MCB-dependent genes occurs before
DNA synthesis and other START events (Dirick et al.
1995; Stuart and Wittenberg 1995). Deletion of
CLN1 and CLN2 may suppress inviability due to mec1
by providing a longer period for preparation for DNA
synthesis, including dNTP accumulation [for which our
results and others (Wang et al. 1997) suggest that RNR1
may be limiting].
The results obtained with deletion of CLN1 and CLN2
may be due to qualitative functional differences between
Cln3p and Cln1p or Cln2p, because the efficiency of
cell cycle transit is lower in cln2 cln3 strains than in cln1
cln2 strains (as measured by cell volume; Lew et al. 1992)
and yet the former, but not the latter, genotype is semiinviable in combination with mec1-1. Additionally, mec1
cln1 cln2 cells expressing high levels of CLN3 from the
GAL promoter are viable; these cells transit through G1
more quickly than CLN strains. Taken together, this
demonstrates that the requirement for MEC1 is not simply correlated with cell volume. Intrinsic qualitative differences between Cln3 and Cln2 have been documented
previously on other grounds (Levine et al. 1996); such
differences can be attributed to differences in efficiency
of transcriptional activation by Cln3p compared to
Cln2p, consistent with the results here. It is likely that
the GAL-CLN3 strains have more transcriptional activation of SCB- and MCB-regulated genes relative to other
START events than the GAL-CLN1 and GAL-CLN2
strains do.
The essential requirement of MEC1 may be identical
to its checkpoint function in HU-treated cells: Although
deletion of CLN1 and CLN2 can suppress the essential
function of MEC1, cells are still sensitive to HU. These
data are consistent with a model suggesting that deletion
of CLN1 and CLN2 does not directly substitute for MEC1
function, but, instead, bypasses the essential requirement for MEC1 by altering the timing of some cell cycle
events. When cells are treated with the ribonucleotide
reductase inhibitor HU, the delay in activation of DNA
synthesis caused by deletion of CLN1 and CLN2 must
no longer suffice. This would be expected as cells must
pause for a longer time, and within S phase (after the
B-type cyclins have already been activated by the CLNs),
until they have accumulated enough nucleotides in the
presence of HU to complete DNA synthesis. However,
in both cases, the requirement for MEC1 is identical:
to restrain DNA replication and/or mitosis when nucleotides are limiting. Nucleotides may be limiting due to
low levels of RNR1, the Rnr inhibitor HU, or the recently
characterized Sml1 protein, which inhibits ribonucleotide reductase (Zhao et al. 1998). Deletion of sml1, like
deletion of cln1 cln2, would function to increase the
levels of active Rnr. In the presence of wild-type SML1,
or CLN1 CLN2, MEC1 function would restrain the cell
cycle until there were adequate levels of dNTPs to com-
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plete S phase. Conversely, deletion of these genes would
lead to an increase in Rnr activity and thereby bypass
the essential requirement for MEC1. While Zhao et al.
suggest the possibility that Mec1p may relieve Sml1p
antagonism of Rnr1p, a simpler explanation, consistent
with our results, is that Sml1p is a partial inhibitor of ribonucleotide reductase that is not regulated by Mec1p.
The presence of Sml1p might then result in a borderline
or insufficient level of deoxyribonucleotides for DNA
replication, thus resulting in a Mec1p requirement for
the same reason that Mec1p is required in HU-treated
cells. This model is simpler in that it accounts for rescue
of mec1 lethality by high-copy RNR1, by deletion of cln1
and cln2 and by sml1 mutation, and does not require
Mec1p to have additional checkpoint functions unrelated to its essential role.
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